Spyre Therapeutics (SYRE) went public on April 7, 2016, when it opened at a split-adjusted price of $250.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
January 2026 | $32.76 | $35.07 | $28.00 | $33.14 | 11,216,172 |
December 2025 | $30.55 | $35.31 | $28.16 | $32.76 | 18,752,400 |
November 2025 | $23.95 | $30.21 | $21.15 | $30.00 | 11,836,900 |
October 2025 | $16.73 | $25.06 | $15.86 | $24.46 | 28,944,500 |
September 2025 | $16.26 | $17.58 | $14.51 | $16.76 | 13,714,000 |
August 2025 | $16.50 | $17.80 | $14.72 | $16.49 | 9,674,200 |
July 2025 | $14.86 | $18.31 | $14.00 | $16.97 | 12,609,300 |
June 2025 | $15.40 | $19.20 | $13.93 | $14.97 | 12,702,500 |
May 2025 | $15.20 | $15.77 | $12.29 | $15.28 | 10,251,100 |
April 2025 | $15.89 | $16.12 | $10.91 | $15.23 | 17,313,000 |
March 2025 | $19.96 | $21.03 | $16.13 | $16.14 | 14,003,400 |
February 2025 | $22.04 | $24.83 | $18.26 | $19.70 | 11,556,100 |
January 2025 | $23.60 | $26.01 | $20.25 | $22.99 | 11,874,427 |
December 2024 | $28.40 | $29.06 | $22.37 | $23.28 | 10,522,943 |
November 2024 | $32.72 | $40.26 | $25.74 | $28.43 | 14,567,842 |
October 2024 | $29.18 | $36.60 | $26.28 | $32.53 | 8,636,201 |
September 2024 | $28.18 | $31.89 | $26.52 | $29.41 | 12,946,429 |
August 2024 | $27.51 | $29.00 | $23.31 | $28.75 | 9,051,156 |
July 2024 | $23.71 | $32.41 | $23.00 | $27.50 | 11,549,285 |
June 2024 | $35.00 | $38.90 | $22.19 | $23.51 | 21,126,345 |
May 2024 | $33.01 | $40.49 | $31.39 | $34.95 | 6,803,819 |
April 2024 | $37.82 | $40.84 | $31.27 | $33.03 | 7,123,369 |
March 2024 | $30.18 | $47.97 | $28.48 | $37.93 | 14,273,294 |
February 2024 | $25.93 | $28.80 | $20.07 | $27.44 | 9,576,670 |
January 2024 | $21.99 | $28.66 | $18.54 | $25.91 | 6,340,165 |
